AVXL financials

Anavex Life Sciences (AVXL) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

AVXL income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$51.41M-$46.38M-0.54
2024––-$52.88M-$43.00M-0.52
2023––-$55.76M-$47.51M-0.60
2022––-$50.99M-$47.98M-0.62
2021––-$42.00M-$37.91M-0.54
2020––-$31.09M-$26.28M-0.45